HER2-positive feline mammary carcinoma

被引：5
|
作者：
Marques, Claudia [1 ]
Correia, Jorge [1 ]
Ferreira, Fernando [1 ]
机构：
[1] Univ Lisbon, Fac Vet Med, Ctr Interdisciplinary Res Anim Hlth, P-1300477 Lisbon, Portugal
来源：
AGING-US | 2016年 / 8卷 / 08期
关键词：
feline mammary carcinoma; HER2-positive subtype; sHER2; cancer model;
D O I：
10.18632/aging.101015
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：1574 / 1575
页数：2
相关论文
共 50 条
  • [1] Effects of Lapatinib on HER2-Positive and HER2-Negative Canine Mammary Carcinoma Cells Cultured In Vitro
    Leis-Filho, Antonio Fernando
    de Faria Lainetti, Patricia
    Emiko Kobayashi, Priscila
    Fonseca-Alves, Carlos Eduardo
    Laufer-Amorim, Renee
    PHARMACEUTICS, 2021, 13 (06)
  • [2] Tyrosine Kinase Inhibitors Are Promising Therapeutic Tools for Cats with HER2-Positive Mammary Carcinoma
    Gameiro, Andreia
    Almeida, Filipe
    Nascimento, Catarina
    Correia, Jorge
    Ferreira, Fernando
    PHARMACEUTICS, 2021, 13 (03) : 1 - 17
  • [3] Meningeal carcinomatosis of HER2-positive Breast Carcinoma
    Preusser, M.
    Berghoff, A.
    Furtner, J.
    Dieckmann, D.
    Bartsch, R.
    TUMORBOARD, 2013, 2 (01): : 15 - 16
  • [4] Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression
    Giusti, Veronica
    Ruzzi, Francesca
    Landuzzi, Lorena
    Ianzano, Marianna L.
    Laranga, Roberta
    Nironi, Elena
    Scalambra, Laura
    Nicoletti, Giordano
    De Giovanni, Carla
    Olivero, Martina
    Arigoni, Maddalena
    Calogero, Raffaele
    Nanni, Patrizia
    Palladini, Arianna
    Lollini, Pier-Luigi
    ONCOGENESIS, 2021, 10 (11)
  • [5] Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression
    Veronica Giusti
    Francesca Ruzzi
    Lorena Landuzzi
    Marianna L. Ianzano
    Roberta Laranga
    Elena Nironi
    Laura Scalambra
    Giordano Nicoletti
    Carla De Giovanni
    Martina Olivero
    Maddalena Arigoni
    Raffaele Calogero
    Patrizia Nanni
    Arianna Palladini
    Pier-Luigi Lollini
    Oncogenesis, 10
  • [6] Treatment of HER2-positive cutaneous apocrine carcinoma of the axilla
    Kamata, Arimichi
    Hino, Koji
    Matsuda, Arisa
    Kamiyama, Koki
    Takasaka, Yoshihiro
    Tazawa, Kenichi
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (04): : 348 - 352
  • [7] Clinicopathologic charateristics of HER2-positive mucinous carcinoma of the breast
    Jang, Y.
    Cho, E. Y.
    Cho, S. Y.
    VIRCHOWS ARCHIV, 2019, 475 : S69 - S70
  • [8] Trastuzumab biosimilar for HER2-positive breast and gastric carcinoma
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (09) : 482 - 483
  • [9] HER2-positive/ER-low breast carcinoma shows a response to neoadjuvant chemotherapy similar to that of HER2-positive/ER-negative breast carcinoma
    Weisman, Paul
    Ospina-Romero, Monica
    Yu, Qiqi
    Wisinski, Kari
    Xu, Jin
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 238
  • [10] The immune microenvironment of HER2-positive ductal carcinoma in situ of the breast
    Ubago, Julianne M.
    Blanco, Luis Z., Jr.
    Siziopikou, Kalliopi P.
    CANCER RESEARCH, 2018, 78 (04)
12345